Corticosteroid therapy for the pregnant asthmatic patient
M. Schatz, R. Patterson, S. Zeitz, J. O'Rourke and H. Melam
Corticosteroids were used during seventy pregnancies in 55 asthmatic
patients. In this series there was one spontaneous abortion and 71 live
births (including two sets of twins). There was no maternal, fetal, or
neonatal deaths. On the basis of recorded gestation, slightly more
premature births were noted in this series than would be expected in the
general population. However, there was no increased incidence of toxemia,
uterine hemorrhage, or congenital malformations when compared to the
general population, Corticosteroids, when indicated for the treatment of
severe asthma, do not appear to noticeably increase the risk of maternal or
fetal complications, and thus should not be contraindicated in pregnancy.
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases
Hoes et al.
Ann Rheum Dis 2007;66:1560-1567.
ABSTRACT
| FULL TEXT
Maternal Asthma Is Associated with Reduced Female Fetal Growth
Murphy et al.
Am. J. Respir. Crit. Care Med. 2003;168:1317-1323.
ABSTRACT
| FULL TEXT
Management of hyperemesis gravidarum: the importance of weight loss as a criterion for steroid therapy
Moran and Taylor
QJM 2002;95:153-158.
ABSTRACT
| FULL TEXT
Respiratory diseases in pregnancy {bullet} 1: Asthma in pregnancy
Nelson-Piercy
Thorax 2001;56:325-328.
FULL TEXT
The Effects of Immunosuppressive and Anti-inflammatory Medications on Fertility, Pregnancy, and Lactation
Janssen and Genta
Arch Intern Med 2000;160:610-619.
ABSTRACT
| FULL TEXT
Factors associated with fetal losses in severe systemic lupus erythematosus
Martinez-Rueda et al.
Lupus 1996;5:113-119.
ABSTRACT
Acute Respiratory Failure in Pregnancy
Hollingsworth et al.
J Intensive Care Med 1989;4:11-34.
ABSTRACT